Effect of GLP-1 Analogue ROSE-010 on Appetite in Overweight and Obese Subjects

Clinical trial NCT06621017 · COMPLETED

Trial details

NCT number: NCT06621017
Sponsor: Rose Pharma Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Obesity; Overweight

Start date: 2024-09-26
Primary completion: 2025-02-27
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.